DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with approximately $535 million in cash ...
Sky Harbour Group (NYSEAMERICAN:SKYH) executives highlighted rapid revenue growth, expanding development activity, and a shift in funding strategy during the company’s 2025 year-end earnings call and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results